Standard
Designing Poly-agonists for Treatment of Metabolic Diseases : Challenges and Opportunities. / Petersen, Jonas; Strømgaard, Kristian; Frølund, Bente; Clemmensen, Christoffer.
In:
Drugs, Vol. 79, No. 11, 2019, p. 1187-1197.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Petersen, J, Strømgaard, K, Frølund, B & Clemmensen, C 2019, '
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities',
Drugs, vol. 79, no. 11, pp. 1187-1197.
https://doi.org/10.1007/s40265-019-01153-6
APA
Petersen, J., Strømgaard, K., Frølund, B., & Clemmensen, C. (2019).
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities.
Drugs,
79(11), 1187-1197.
https://doi.org/10.1007/s40265-019-01153-6
Vancouver
Petersen J, Strømgaard K, Frølund B, Clemmensen C.
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities.
Drugs. 2019;79(11):1187-1197.
https://doi.org/10.1007/s40265-019-01153-6
Author
Petersen, Jonas ; Strømgaard, Kristian ; Frølund, Bente ; Clemmensen, Christoffer. / Designing Poly-agonists for Treatment of Metabolic Diseases : Challenges and Opportunities. In: Drugs. 2019 ; Vol. 79, No. 11. pp. 1187-1197.
Bibtex
@article{a43972bad44447b99bd13afba6736b82,
title = "Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities",
author = "Jonas Petersen and Kristian Str{\o}mgaard and Bente Fr{\o}lund and Christoffer Clemmensen",
year = "2019",
doi = "10.1007/s40265-019-01153-6",
language = "English",
volume = "79",
pages = "1187--1197",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "11",
}
RIS
TY - JOUR
T1 - Designing Poly-agonists for Treatment of Metabolic Diseases
T2 - Challenges and Opportunities
AU - Petersen, Jonas
AU - Strømgaard, Kristian
AU - Frølund, Bente
AU - Clemmensen, Christoffer
PY - 2019
Y1 - 2019
U2 - 10.1007/s40265-019-01153-6
DO - 10.1007/s40265-019-01153-6
M3 - Journal article
C2 - 31243696
VL - 79
SP - 1187
EP - 1197
JO - Drugs
JF - Drugs
SN - 0012-6667
IS - 11
ER -